The State Administration for Market Regulation released the "List of Cases of Unconditional Approval of Concentration of Undertakings from February 9 to February 22, 2026", which includes the case of Guangzhou Pharmaceutical Co., Ltd.'s acquisition of the equity of Zhejiang Pharmaceutical Industry Co., Ltd.